Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of €337.94 million as of December 5, 2025. Its market cap has decreased by -43.46% in one year.

Market Cap

337.94M

Enterprise Value

249.76M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.80

Market Cap Chart

Since April 13, 2006, Anavex Life Sciences's market cap has increased from 264.36K to 337.94M, an increase of 127,733.67%. That is a compound annual growth rate of 43.89%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	340.94M	-61.25%
Dec 31, 2024	879.86M	27.26%
Dec 29, 2023	691.39M	2.35%
Dec 30, 2022	675.51M	-41.72%
Dec 31, 2021	1.16B	292.09%
Dec 31, 2020	295.61M	128.22%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	248.18B
Siemens Aktiengesellschaft	181.89B
Allianz SE	139.43B
Deutsche Telekom AG	131.24B
Siemens Energy AG	99.98B
Rheinmetall AG	70.18B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.26B
Deutsche Bank Aktiengesellschaft	59.33B

Market Cap Rankings